Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FX2DW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $147,412
Award facts
- Contract value 100% obligated
- $147,412.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order on September 2, 2025, by the Defense Logistics Agency (DLA) for the supply of Keytruda 100 mg/4 mL vials. The contract carries a ceiling value of $147,412.08 under a firm fixed-price delivery order structure with an ultimate completion date of September 23, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its woman-owned small business status. The place of performance is Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA's SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent IDC authorizes the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting Department of Defense healthcare facilities worldwide, encompassing branded and generic prescription drugs, biologics, over-the-counter medications, and medical consumables. The current award for Keytruda, a specialized oncology therapeutic, represents one of numerous delivery orders issued under this vehicle to support military health system requirements.
Quick answers
Who was awarded contract SPE2DB25FX2DW?
SPE2DB25FX2DW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FX2DW worth?
The government has obligated $147,412 on SPE2DB25FX2DW.
Is contract SPE2DB25FX2DW an order under another contract?
Yes. SPE2DB25FX2DW is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2DW competed?
The extent of competition for SPE2DB25FX2DW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award